RAD51B and uterine corpus sarcoma: With the increasing use of next-generation sequencing, recognition of RAD51B-rearranged uterine sarcomas has grown, and they are now regarded as a distinct molecular subgroup of uterine sarcomas with diverse morphologic manifestations but a typically malignant clinical course [128].